Stock Updates

Today’s Top Gainers in the Market Amgen Inc. (NASDAQ:AMGN) from Healthcare

Today’s top gainers include the company Amgen Inc. (NASDAQ:AMGN) which is in the industry Biotechnology, gaining 0.13% today. In the last week its performance is 1.46%, and 2.19% for the past quarter. Currently, Amgen Inc., AMGN has a target price of 184.12, so today’s gain of 0.13% is a significant step towards its target price. The GAP today is therefore 0.02%.

Amgen Inc. (NASDAQ:AMGN), has a market cap of 124749.51, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 81.60%.

At the current price of 165.89, it has a dividend yield of 2.41%, and its target price is 184.12. This is with a profit margin of 32.60%, and total debt/equity of 1.2. Amgen Inc. (NASDAQ:AMGN) has a P/E of 17.53, as well as a forward P/E of 13.53.

With a current EPS of 9.45, and a forecasted EPS growth for next year at 9.59%,Amgen Inc. (NASDAQ:AMGN) has had a EPS growth for the past five years at 13.60%. For the next five years EPS growth is projected to be 8.48%.

Performance for the year is 3.32%. Since its IPO date on 9/7/1984, the total performance to date is 3.44%.

Volume today for Amgen Inc. (NASDAQ:AMGN), is 943926, while its average volume is 2807.63. Whilst the total gain today was 0.13%, it did have a day high of -0.27%.

Volatility for this week has been at 1.19%, and 1.59% for the month. The 52-week low for Amgen Inc., AMGN has been 29.90%, while the 52-week-high has reached -6.62%.

Looking at its return of investments, which is 12.50%, and its return on assets is 10.00%. Amgen Inc. (NASDAQ:AMGN) has an operating margin of 39.90%. With a sales growth of 9.80% quarter over quarter. Bearing in mind that Amgen Inc., AMGN is in the sector Healthcare, its long-term debt/equity is 1.12, and has a current ratio of 5 and 4.7 for quick ratio.

So what is the value of Amgen Inc.? Well its PEG is 2.07, and the P/S is 5.63, along with a P/B of 4.35. Meanwhile it has a p/cash of 3.59.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment